Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A woman with a rare ovarian tumor and hyperparathyroidism improved after surgery, highlighting the need for reporting unusual cases to understand and manage rare diseases.

Dutasteride and minoxidil helped regrow hair in a woman with breast cancer.

Erlotinib can cause persistent excessive hair growth.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Postmenopausal women with past hirsutism or irregular periods have more heart and lung diseases.

Nestin helps identify certain melanoma cells in nodular melanoma.

A woman's excessive hair growth was caused by a rare benign tumor in her adrenal gland, which was successfully removed.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

Leydig cell tumors can cause high testosterone in women and are treated by removing the ovaries.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

A 50-year-old woman with breast cancer developed an autoimmune skin disorder, highlighting the need for thorough checks and team-based treatment.

Overexpression of E2F1 can lead to skin tumors and disrupt hair growth.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Ovarian hyperthecosis caused high testosterone and virilization symptoms in a 60-year-old woman, which improved after surgery.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Cetuximab can cause unusual hair growth and hair loss.

All women with significant unwanted hair growth have hormonal imbalances, often from polycystic ovary syndrome.

Slovak breast cancer survivors have moderate quality of life, with emotional and cognitive strengths but social and physical challenges, needing targeted support.

A new genetic region, 17q21.31, is linked to higher ovarian cancer risk.

Examining more lymph nodes can improve survival rates in breast cancer patients without lymph node involvement.

Mice with a specific BRCA1 mutation have a higher risk of tumors, especially in the uterus and ovaries.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Skin cells can naturally limit the growth of cancerous changes by balancing cell renewal and differentiation.

A 90-year-old woman's hand lesion was a rare, aggressive skin cancer treated successfully with surgery.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

A thorough diagnostic process and teamwork are crucial for managing complex hyperandrogenism in postmenopausal women.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Hair growth-promoting nutraceuticals do not block the cancer-fighting effects of tamoxifen and may enhance its action.